National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

riluzole
A benzothiazole derivative with neuroprotective and potential anti-depressant and anxiolytic activities. While the mechanism of action of riluzole is unknown, its pharmacological activities in motor neurons include the following, some of which may be related to its effect: 1) an inhibitory effect on glutamate release, 2) inactivation of voltage-dependent sodium channels, and 3) interference with intracellular events that follow transmitter binding at excitatory amino acid receptors. In animal models, this agent has been shown to exhibit myorelaxant and sedative activities, apparently due to the blockade of glutamatergic neurotransmission. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Rilutek
Chemical structure name:2-amino-6-(trifluoromethoxy)benzothiazole



Previous:riboflavin, ribosome-inactivating protein CY503, Riboxamide, rifabutin, Rilutek
Next:risedronate sodium, Ritalin, ritonavir, Rituxan, rituximab

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov